106 tracked 13F filers disclose a position in ANRO as of the latest SEC 13F filings, a combined $537.0M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Commodore Capital LP | $61.2M | 2.7M | ▲+49% Added · +900K sh | Q1 2026 | |
| 2 | Vestal Point Capital, LP | $46.4M | 2.1M | ▼−17% Reduced · −421K sh | Q1 2026 | |
| 3 | PERCEPTIVE ADVISORS LLC | $45.2M | 2.0M | ▲+13% Added · +226K sh | Q1 2026 | |
| 4 | Spruce Street Capital LP | $35.7M | 1.4M | ▲+2.1% Added · +28K sh | Q2 2026 | |
| 5 | Vivo Capital, LLC | $31.9M | 1.2M | ▲+17% Added · +173K sh | Q2 2026 | |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | $27.1M | 1.2M | →First observed position No prior filed position | Q1 2026 | |
| 7 | FRANKLIN TEMPLETON INC | $24.8M | 1.1M | ▼−1.6% Reduced · −18K sh | Q1 2026 | |
| 8 | ARMISTICE CAPITAL, LLC | $20.5M | 912K | ▼−41% Reduced · −624K sh | Q1 2026 | |
| 9 | MILLENNIUM MANAGEMENT LLC | $18.5M | 822K | ▲+30% Added · +192K sh | Q1 2026 | |
| 10 | STATE STREET CORP | $18.1M | 686K | ▲+244% Added · +486K sh | Q2 2026 | |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | $17.9M | 678K | ▲+132% Added · +385K sh | Q2 2026 | |
| 12 | BlackRock, Inc. | $15.0M | 666K | ▲+9.6% Added · +58K sh | Q1 2026 | |
| 13 | Ikarian Capital, LLC | $11.6M | 515K | —Held | Q1 2026 | |
| 14 | Point72 Asset Management, L.P. | $11.3M | 503K | ▼−69% Reduced · −1.1M sh | Q1 2026 | |
| 15 | Integral Health Asset Management, LLC | $13.2M | 500K | —Held | Q2 2026 | |
| 16 | Venrock Adviser, LLC | $11.2M | 500K | ▲New +500K sh | Q1 2026 | |
| 17 | Affinity Asset Advisors, LLC | $11.2M | 500K | ▲New +500K sh | Q1 2026 | |
| 18 | NORTHERN TRUST CORP | $10.6M | 473K | ▼−0.2% Reduced · −970 sh | Q1 2026 | |
| 19 | JENNISON ASSOCIATES LLC | $8.7M | 386K | ▲New +386K sh | Q1 2026 | |
| 20 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $8.7M | 385K | ▲New +385K sh | Q1 2026 | |
| 21 | PRICE T ROWE ASSOCIATES INC /MD/ | $8.3M | 371K | ▲12× Added · +341K sh | Q1 2026 | |
| 22 | Schonfeld Strategic Advisors LLC | $6.8M | 258K | ▲New +258K sh | Q2 2026 | |
| 23 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.4M | 238K | ▲+102% Added · +120K sh | Q1 2026 | |
| 24 | ALKEON CAPITAL MANAGEMENT LLC | $5.1M | 227K | ▼−52% Reduced · −250K sh | Q1 2026 | |
| 25 | TWO SIGMA INVESTMENTS, LP | $4.9M | 216K | ▲+54% Added · +76K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 16 funds opened a new position in ANRO and 18 added to an existing one, while 14 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 50 funds | $31.2B |
| NVIDIA CORPNVDA | 49 funds | $150.0B |
| MICROSOFT CORPMSFT | 49 funds | $99.7B |
| LAM RESEARCH CORPLRCX | 48 funds | $12.1B |
| AMAZON.COM INCAMZN | 47 funds | $73.6B |
| ALPHABET INC-CL AGOOGL | 47 funds | $65.9B |
| BROADCOM INCAVGO | 47 funds | $61.8B |
| META PLATFORMS INC-CLASS AMETA | 47 funds | $46.4B |
| REGENERON PHARMACEUTICALSREGN | 47 funds | $6.5B |
| COGENT BIOSCIENCES INCCOGT | 47 funds | $872.8M |
| APPLE INCAAPL | 46 funds | $113.3B |
| ADVANCED MICRO DEVICESAMD | 46 funds | $14.0B |
Ranked by how many of ANRO's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jul 10, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy (P) | 3K | $39K |
| Jul 9, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy (P) | 11K | $134K |
| Jul 9, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy (P) | 1K | $18K |
| Mar 28, 2024 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Buy (P) | 2K | $25K |
| Mar 28, 2024 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Buy (P) | 5K | $75K |
| Feb 6, 2024 | Alpha Wave Global, LP | 10% Owner | Buy (P) | 600K | $9.6M |
| Feb 6, 2024 | Etkin Amit | PRESIDENT AND CEO, Director | Buy (P) | 3K | $50K |
| Feb 6, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy (P) | 17K | $272K |
| Feb 6, 2024 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | Buy (P) | 2K | $25K |
Connected entities for ANRO
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/ANRO/capital-change-brief"
Use Arkolith's capital_change_brief for ANRO. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for ANRO. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.